Gilead Sciences' Q3 2024 results exceeded expectations, driven by a strong performance of the HIV portfolio. Read why I ...

Gilead stock sprinted to a profit-taking zone Thursday after Gilead Sciences rode its Covid treatment to another beat and ...

Gilead Sciences (GILD) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term.

or 22.55% annualized — at Stock Options Channel we call this the YieldBoost. Below is a chart showing the trailing twelve month trading history for Gilead Sciences Inc, and highlighting in green ...

As investors rotate out of the tech sector, there are plenty of compelling opportunities in other corners of the market. I used the InvestingPro Stock Screener and Fair Value ...

And when a stock's fair value is higher than ... along with three other factors related to earnings estimates, Gilead is rated Zacks Rank #3 (Hold). The chart below shows the evolution of the ...

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...

GILD). The affirmation of the stock's rating and target... On Monday, TD Cowen sustained its Buy rating on Gilead Sciences (NASDAQ:GILD) stock, with a steadfast price target of $85.00. The firm's ...

The agreement provides Gilead access... ByInvesting.com • 20 Feb 2024 Gilead stock price target cut to $75 by RBC on commercial outlook On Wednesday, RBC Capital adjusted its price target on shares of ...